Robert Farrell
Comptroller/Controller/Auditor bei MORPHIC HOLDING, INC.
Vermögen: 986 771 $ am 30.04.2024
Profil
Robert E.
Farrell's current job(s) include serving as the Treasurer & Chief Accounting Officer at Morphic Holding, Inc. since 2020, and as the Chief Accounting Officer & Senior Vice President at Morphic Therapeutic, Inc. since 2015.
Mr. Farrell's former job(s) include working as the Senior Director-Finance at PPD Dermatology LLC, as the Controller at Oscient Pharmaceuticals Corp., as the Vice President-Finance at NeoGenesis Pharmaceuticals, Inc., and as the Treasurer & VP-Finance & Administration at Genocea Biosciences, Inc. from 2009 to 2015.
Mr. Farrell obtained his undergraduate degree from Bentley University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MORPHIC HOLDING, INC.
0,06% | 01.04.2024 | 35 267 ( 0,06% ) | 986 771 $ | 30.04.2024 |
Aktive Positionen von Robert Farrell
| Unternehmen | Position | Beginn |
|---|---|---|
| MORPHIC HOLDING, INC. | Comptroller/Controller/Auditor | 01.06.2015 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Comptroller/Controller/Auditor | 01.06.2015 |
Ehemalige bekannte Positionen von Robert Farrell
| Unternehmen | Position | Ende |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Verwaltungsdirektor | 01.03.2015 |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Comptroller/Controller/Auditor | - |
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Finanzdirektor/CFO | - |
PPD Dermatology LLC
 PPD Dermatology LLC Pharmaceuticals: MajorHealth Technology PPD Dermatology LLC develops novel pharmaceutical products and proprietary medical therapies for the dermatology market. The company provides therapies for skin diseases. It was founded in 2006 and is headquartered in Waltham, MA. | Finanzdirektor/CFO | - |
Ausbildung von Robert Farrell
| Bentley University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| MORPHIC HOLDING, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
PPD Dermatology LLC
PPD Dermatology LLC Pharmaceuticals: MajorHealth Technology PPD Dermatology LLC develops novel pharmaceutical products and proprietary medical therapies for the dermatology market. The company provides therapies for skin diseases. It was founded in 2006 and is headquartered in Waltham, MA. | Health Technology |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |